Skip to main content
. 2025 Feb 12;111(13):e324908. doi: 10.1136/heartjnl-2024-324908

Table 1. Baseline characteristics by quarters of age.

Age groups (years) P value
<67(n=285) ≥67–≤73 (n=284) >73–≤79 (n=283) >79(n=285)
Age (years) 60 (55, 64) 72 (67, 72) 76 (75, 78) 83 (81, 86)
Women 85 (30) 84 (30) 62 (22) 69 (24) 0.077
White 242 (85) 265 (93) 262 (93) 274 (96) <0.001
Recruitment context 0.93
 In hospital 38 (13) 42 (15) 39 (14) 45 (16)
 Recent discharge 58 (21) 49 (17) 49 (17) 52 (18)
 Ambulatory patient 189 (66) 193 (68) 195 (69) 188 (66)
Systolic BP (mm Hg) 114 (103, 130) 118 (106, 132) 122 (109, 133) 120 (108, 132) 0.003
LVEF (%) 30 (25, 35) 35 (27, 38) 35 (28, 38) 34 (25, 39) 0.001
BMI 29.0(24.9–33.5) 29.7(25.9–33.8) 28.1(24.6–32.3) 27.0(23.6–29.9) <0.001
NYHA III/IV 107 (38) 120 (42) 121 (43%) 141 (49) 0.038
Ischaemic aetiology 154 (54) 168 (59) 159 (56) 166 (58) 0.61
Atrial fibrillation 85 (30) 132 (46) 153 (54) 164 (58) <0.001
Hypertension 120 (42) 159 (56) 170 (60) 163 (57) <0.001
Diabetes 139 (49) 143 (50) 137 (48) 102 (36) 0.001
Hb (g/dL) 12.3 (11.2, 12.9) 12.1 (11.3, 12.9) 12.1 (11.2, 12.8) 11.8 (11.1, 12.7) 0.079
TSAT (%) 15 (10, 19) 15 (11, 20) 16 (11, 19) 16 (11,21) 0.32
TSAT <20% 221 (79) 207 (75) 208 (76) 205 (73) 0.44
Ferritin (ng/mL) 54 (28, 90) 48 (28, 82) 48 (31, 85) 49 (30, 84) 0.77
eGFR (mL/min/1.73 m2) 64 (48, 86) 54 (39, 71) 47 (37, 73) 44 (34, 55) <0.001
NT-proBNP (ng/L)* 1203 (607, 3023) 1414 (820, 2823) 1686 (964, 3602) 2745 (1570, 4822) <0.001

Continuous variables are summarised as median (lower quartile, upper quartile) and categorical variables as counts and percentages.

*

NT-proBNP was recorded only in a subset of ambulatory patients: 142, 136, 144 and 143 patients had NT-proBNP recorded for age groups <67 years, ≥67–≤73 years, >73–≤79 years and >79 years, respectively.

BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; FDI, intravenous ferric derisomaltose; Hb, haemoglobin; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal-pro B-type natriuretic peptide; NYHA, New York Heart Association; TSAT, transferrin saturation.